Cleveland Clinic Diabetes Therapeutics, Tekinolosi ma Ta'otoga 2021
O LE A E MAUA LE FAʻAMATALAGA VIA LIFETIME DOWNLOAD LINK (Vave Vave) Ina ua maeʻa totogi
Mo le silia ma le luasefululima tausaga, Cleveland Falemai has been at the forefront of diabetes treatment, research and education. Its world class faculty has designed Togafitiga ma'i Suka, Tekinolosi ma Ta'otoga to provide up-to-date reviews of management strategies and research on the complications of this disease. It includes a detailed analysis of therapeutic options applicable to type 1 and type 2 diabetes, as well as their complications
Aso Ma'isuka, Togafitiga, Tekinolosi ma Ta'otoga, o loʻo tuʻuina atu e le Cleveland Clinic Department of Endocrinology, Diabetes and Metabolism e tuʻuina atu ai iloiloga lata mai o taʻiala tau pulega ma suʻesuʻega i faʻafitauli o le maʻisuka. O vaega autu autu o le a talanoaina e aofia ai le toe iloiloina o filifiliga togafitiga e pulea uma ai le maʻisuka ituaiga 1 ma le 2 ma faʻalavelave, e aofia ai le faʻafouina o le pamu, togafitiga lua hormone, sulfonylureas, GLP1 agonists, metformin, ma le matafaioi o le faamalositino ma le anapogi. O lenei tausaga fou o se talanoaga o le pathophysiologic aafiaga ole COVID-19. O le sini o lenei kosi o le fa'ateleina lea o le agava'a o foma'i ma galuega fa'afoma'i e togafitia ai le ma'i suka ma ona fa'alavelave ma, mulimuli ane, fa'aleleia taunu'uga o gasegase.
E le gata i le mauaina o fa'ata'ita'iga a le failauga a'o le'i a'o mai a'o le'i mae'a vasega, o le a tu'uina atu i tagata auai le avanoa i le kosi fa'asalalau fa'asalalau fa'asalalau.
A maeʻa ona auai i lenei gaioiga faʻasalalau, o le a mafai e fomaʻi ona:
- Fa'amatala le aoga ma a'afiaga o togafiti fa'afouga mo le ma'isuka ituaiga 1, e aofia ai pamu inisalini tapuni tapuni, togafitiga homone lua, ma le glucagon.
- Fa'atusatusa le aoga o togafitiga fou ma togafitiga fou mo le ma'isuka ituaiga 1 ma le 2.
- Iloiloga fa'apitoa le a'afiaga o le taotoga bariatric i tagata mama'i e maua i le ma'isuka ituaiga 2.
- Fa'amatala filifiliga mo le togafitia o tamaiti e maua i le ma'isuka ituaiga 2.
- Fa'atusatusa fa'amaumauga ile aoga ole taumafa ma fa'amalositino ile ma'i suka.
- Aotele su'esu'ega e fa'amalamalamaina ai le a'afiaga o le pathophysiologic o le steatohepatitis e le o le ava malosi.
- Fa'amatala pe fa'afefea ona a'afia e le COVID-19 le alualu i luma o le ma'i suka i tagata mama'i mama'i.
Cleveland Clinic Diabetes Therapeutics, Tekinolosi ma Ta'otoga
Vaega 1: Ituaiga Ma'isuka Tulaga 1
| Fa'afouga pamu | Diana Isaacs, PharmD, BCPS, BC-ADM, CDE |
| Pamu Hormone Lua | Keren Zhou, MD |
| Fai e Oe Lava Tekinolosi | Julia Blanchette, PhD, RN, CDCES |
| Inisalini Fou | Robert S. Zimmerman, MD |
| Taeao o Glucagon | Vinni Makin, MD |
Vaega 2: Taulai ile Ma'isuka Ituaiga 2
| I'uga o le fatu o le ta'otoga bariatric i ma'i e maua i le puta puta ma le suka | Ali Aminian, MD |
| O Sulfonyureas Saogalemu? | Pratibha Rao, MD |
| Togafitiga o le Ma'isuka Ituaiga 2 i Tamaiti | Jamie Wood, MD |
| Togafitiga Fou mo le Ma'i Suka ma le Fatuga'o | Alexandra Michael, MD |
| GLP-1 Agonists: Oral VS. SubQ | Mario Skugor, MD |
| Ole fa'ama'i ga'o ole ava ole ate (NAFLD) ose fa'aaliga vave o le ma'i fa'ama'i. | Adi Mehta, MD |
| Togafitiga ole Hyperlipidemia ile Ma'isuka Ituaiga 2: Iloiloga o Ta'iala o lo'o iai nei | Dennis Bruemmer, MD, PhD |
Vasega 3: Anapogi, Metformin ma le Pulega Fa'afitauli
| Anapogi vavao ma le ma'i suka: O le a le Fa'amaoniga? | Carolyn Garvey, RDN, LD, CDCES |
| Puleaina ole Hypoglycemia Post Gastric Bypass | Sangeeta Kashyap, MD |
| Matafaioi a le faamalositino i le puleaina o le ma'i suka | Oscar Morey Vargas, MD |
| Malamalama i gaioiga a Metformin e ala i fesoʻotaʻiga i totonu o le gutu | Leann Olansky, MD |
| T2D ma le CVD: Metformin Monotherapy | Kevin M. Pantalone, DO, ECNU, FACE |
| Puleaina o le Ma'isuka ile gasegase ile COVID-19 | Sana Hasan, DO |
| Vaega Endoscopic ma Ta'otoga ole Gastric Pylorus mo Gastroparesis | Joshua Landreneau, MD |
Aso Faamatuu: 7/1/21